Delivery Order SPE2DB22D2007-SPE2DB25FJ4UF
- Not listed
- The Defense Logistics Agency awarded a $24,368.92 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This delivery order, issued without set-aside designation, is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AYVAKIT is a tyrosine kinase inhibitor used in the treatment of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $24.4K and is structured as a firm fixed price delivery order, with an ultimate completion date of September 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of AYVAKIT 25 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $73,106.76, is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency Medical Supply Chain awarded a $48,737.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This competitive award, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product AYVAKIT 25 MG TABLET 30S. The order has a ceiling value of $23,325.68 and is a firm fixed-price contract. The ultimate completion date for this delivery order is August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a potential value of up to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packaging) under a firm fixed price contract valued at approximately $24.4K. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product AYVAKIT 25 MG TABLET 30S. The contract has a ceiling value of $23,325.68 and is a firm-fixed-price contract. The period of performance extends through October 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 firm fixed-price delivery order is for the supply of the drug AYVAKIT 25 MG TABLET 30S. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 18, 2025, provides for the supply of AYVAKIT 25 mg tablets (30-count units) valued at $24,368.92 with a completion date of September 9, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, awarded competitively through the Defense Logistics Agency (DLA), which procures medical supplies for the Department of Defense. Performance will be conducted from the contractor's corporate office in...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4UFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units, with a ceiling value of $24,368.92. This is a firm fixed-price delivery order under a competitively awarded, non-set-aside contract. The award is set to conclude by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AYVAKIT is a tyrosine kinase inhibitor used in the treatment of gastrointestinal stromal tumors, representing a specialized pharmaceutical product within the company's broader federal medical supply portfolio. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves multiple federal healthcare systems including the Defense Health Agency and U.S. Coast Guard, demonstrating its established capacity to fulfill specialized and time-sensitive medical supply requirements across the Department of Defense healthcare network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 9/9/25 |